NCT03021811

EUREKA Italy - Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management

EUREKA Italy - The Evaluation of Real-life Use of KLOX BioPhotonic System in Chronic Wounds Management: a Reproducibility Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: KLOX Technologies Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Multi-center, prospective, interventional, uncontrolled open-label study evaluating the real-life use of KLOX LumiHeal BioPhotonic System in chronic wounds management (venous leg ulcers, diabetic foot ulcers, pressure ulcers).

Conditions

• Venous Leg Ulcer
• Diabetic Foot Ulcer
• Pressure Ulcer

Interventions

Type	Name	Description
DEVICE	KLOX LumiHeal BioPhotonic System	Real-life use of KLOX LumiHeal BioPhotonic System in combination with standard of care.

Timeline

• Start date: 2015-10-01
• Primary completion: 2016-12-01
• Completion: 2017-04-01
• First posted: 2017-01-16
• Last updated: 2017-08-18